French version of FACT-G: Validation and comparison with other cancer-specific instruments

被引:61
作者
Conroy, T [1 ]
Mercier, M
Bonneterre, J
Luporsi, E
Lefebvre, JL
Lapeyre, M
Puyraveau, M
Schraub, S
机构
[1] Ctr Alexis Vautrin, Dept Med Oncol, F-54500 Vandoeuvre Les Nancy, France
[2] Med Pharmaceut Univ, Besancon, France
[3] Ctr Oscar Lambret, F-59020 Lille, France
[4] Ctr Paul Str, Strasbourg, France
关键词
validation; quality of life; FACT-G; EORTC QLQ-C30; FLIC; breast cancer; colorectal cancer; head and neck cancer;
D O I
10.1016/j.ejca.2004.06.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the validity of the French version of the Functional Assessment of Cancer Therapy - General (FACT-G), and to compare its psychometric properties with those of two other cancer-specific quality of life questionnaires, European Organisation for Research and Treatment of Cancer Quality of Life - Core 30 (EORTC QLQ-C30) and Functional Living Index - Cancer (FLIC). Two hundred and twenty three patients with breast or colorectal cancer completed the FACT-G questionnaire in French followed by (in random order) the QLQ-C30 and FLIC. An additional 87 patients with head and neck (H&N) cancer completed the FACT-H&N followed by the QLQ-C30 and H&N-Besanqon. The French version of FACT-G was internally consistent, and its reproducibility was excellent. FACT-G Physical Well-Being and global scores correlated with all QLQ-C30 subscales. There was evidence of discriminant validity. Compared with the other tools, FACT-G included a statistically significantly higher proportion of items patients considered to be confusing or upsetting. Patients with breast or colorectal cancer expressed a preference for QLQ-C30. Use of the specific H&N additional items increased the responsiveness to change of FACT-G. The French version of FACT-G is valid and has psychometric properties similar to those of FLIC and QLQ-C30. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2243 / 2252
页数:10
相关论文
共 25 条
[11]   Quality of life measurement in oncology -: a matter of the assessment instrument? [J].
Holzner, B ;
Kemmler, G ;
Sperner-Unterweger, B ;
Kopp, M ;
Dünser, M ;
Margreiter, R ;
Marschitz, I ;
Nachbaur, D ;
Fleischhacker, WW ;
Greil, R .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (18) :2349-2356
[12]   Comparison of two quality-of-life instruments for cancer patients:: The functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 [J].
Kemmler, G ;
Holzner, B ;
Kopp, M ;
Dünser, M ;
Margreiter, R ;
Greil, R ;
Sperner-Unterweger, B .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2932-2940
[13]   A comparison of two quality-of-life questionnaires for cancer clinical trials: The functional living index-cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30) [J].
King, MT ;
Dobson, AJ ;
Harnett, PR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (01) :21-29
[14]  
Leplege A., 2001, Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interpretation des scores
[15]   COMPARISONS OF 5 HEALTH-STATUS INSTRUMENTS FOR ORTHOPEDIC EVALUATION [J].
LIANG, MH ;
FOSSEL, AH ;
LARSON, MG .
MEDICAL CARE, 1990, 28 (07) :632-642
[16]  
List MA, 1996, CANCER-AM CANCER SOC, V77, P2294, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.3.CO
[17]  
2-T
[18]  
Mercier M, 1998, B CANCER, V85, P180
[19]  
Michelson H, 2000, ACTA ONCOL, V39, P477
[20]  
Osoba D, 1997, QUAL LIFE RES, V6, P103